Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Oct. 27, 2012	Oct. 29, 2011
Cash flows from operating activities:
Net income (loss)	$ 1,907	$ 9,171
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	11,278	9,028
Amortization of deferred gain from sale-leaseback	(1,099)	(1,099)
Deferred income taxes, net of valuation allowance	2,242	576
Stock based compensation expense	874	1,276
Issuance of common stock to Board of Directors	114	108
Changes in operating assets and liabilities:
Accounts receivable	(57)	(166)
Inventories	(11,913)	(22,050)
Prepaid expenses	(825)	(2,095)
Other assets	39	79
Accounts payable	4,712	15,840
Income taxes payable		(242)
Accrued expenses and other current liabilities	1,092	1,240
Net cash provided by operating activities	8,364	11,666
Cash flows from investing activities:
Additions to property and equipment	(21,335)	(10,956)
Net proceeds from sale of subsidiary, LP Innovations, Inc.	204	207
Net cash used for investing activities	(21,131)	(10,749)
Cash flows from financing activities:
Net borrowings under credit facility	7,612
Proceeds from the issuance of common stock under option program		594
Net cash provided by financing activities	7,612	594
Net change in cash and cash equivalents	(5,155)	1,511
Cash and cash equivalents:
Beginning of the period	10,353	4,114
End of the period	$ 5,198	$ 5,625